Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin N-of-1 trial for stimulant-associated insomnia in children with ADHD
ACTRN12614000542695Phase 4Recruiting
- Sponsor
- The University of Queensland
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in Insomnia, sponsored by The University of Queensland. Primary endpoint: Mean change in sleep onset latency. Started Jun 2014; status: recruiting.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on ACTRN12614000542695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000542695.